WEDNESDAY, Nov. 29, 2023 (Healthday News) -- The diabetes drug Mounjaro prompted more weight loss among overweight and obese adults than Ozempic did in a real-world setting, researchers report.

Both Mounjaro (tirzepatide) and Ozempic (semaglutide) mimic the effects of the gut hormone GLP-1, which triggers insulin production, helps control appetite and slows the movement of food through th...

Retatrutide, an experimental weight-loss drug that could compete against blockbusters Wegovy and Zepbound, may work wonders for obese folks with liver disease, new research shows.

A wider study, published in June, found that retatrutide helped obese people lose about a quarter of their sta...

MONDAY, Nov. 13, 2023 (Healthday News) -- In a finding that could change the landscape of heart disease care, the wildly popular weight-loss drug Wegovy has proved its mettle in protecting the heart after lowering the risk of cardiac problems in patients by 20%.

The results from this large, international study had been eagerly awaited by scientists and doctors alike. Why? It is the first ...

The U.S. Food and Drug Administration has received at least three reports of people being hospitalized after taking counterfeit versions of the wildly popular weight-loss drugs known as semaglutides.

At least one of these reports includes mention of a counterfeit version of the Novo Nordisk medication Ozempic, CBS News reported.

Ozempic and Wegovy, another semaglutide med...

When doctors advise patients to lose weight, an optimistic approach is more likely to get results.

Researchers found that patients were more likely to participate in the recommended program and shed pounds if doctors presented obesity treatments as an “opportunity.” They compared that upbeat approach to emphasizing the negative consequences of obesity or using neutral language. <...

A new trial demonstrates the power of the diabetes drug Mounjaro in fighting obesity, helping folks who used the medication lose about 60 pounds.

"In this study, people who added tirzepatide [Mounjaro] to diet and exercise saw greater, longer-lasting weight reduction than those taking placebo," Dr. Jeff Emmick<...

As many doctors and patients hail the advent of weight-loss drugs like Ozempic and Wegovy as the perfect fix for obesity, some experts are urging caution.

The drugs are not well-tolerated by everyone struggling with obesity. For some folks, the weight piles back on as soon as the medication stops. There are also financial and ethical considerations, according to a commentary published onl...

While many have raved about the powers of popular weight-loss drugs like Wegovy and Ozempic, new research confirms the medications can trigger some nasty gastrointestinal side effects.

Known as GLP-1 agonists, they may increase the risk of stomach paralysis, pancreatitis and bowel obstruction, scientists found.

"Although the incidence of these adverse events are relatively rare, af...

Ozempic, a type 2 diabetes drug that has increasingly been used to help with weight loss, will now be labeled as having the potential to block intestines.

The U.S. Food and Drug Administration recently made the label update for the drug made by ...

When it comes to staying trim, timing may be everything.

That's according to new research that found adults who routinely engaged in moderate-to-vigorous exercise early in the morning were less likely to be overweight or obese than those who worked out later in the day.

“For individuals who exercise regularly, their body mass index [BMI] is 2 units lower and waist circumference is...

Low-carb diets may be all the rage, but they're not for kids with diabetes, according to the American Academy of Pediatrics (AAP).

In a new report, the AAP says that low-carbohydrate diets cannot be recommended for children or teenagers with either type 1 or type 2 diabetes. That's because there's little evidence they're helpful, but there are concerns about restricting kids' diets to tha...

The blockbuster drug Ozempic has become a household name for its ability to spur weight loss. Now an early study hints at an intriguing possibility: The drug might allow people newly diagnosed with type 1 diabetes to drop their daily insulin shots.

Experts emphasized that the findings

Weight-loss drugs like Ozempic and Wegovy are surging in popularity, but that doesn't mean they're good for everyone.

Glucagon-like peptide-1 receptor agonists (GLP-1RA) may be dangerous for children, warned researchers at University of California, Irvine.

Treating childhood obesity and type 2 diabetes with these injected medications may have unintended and adverse consequences in p...

For women, keeping a stable weight after the age of 60 may boost their odds of reaching the advanced ages of 90, 95 or even 100.

Older women with a more stable weight were 1.2 to 2 times more likely to live that long than those who lost 5% or more of their weight, the study showed.

Women who unintentionally lost weight were 51% less likely to survive to the age of 90. Gaining ...

Weight-loss drug Wegovy (semaglutide) and its diabetes-focused cousin, Ozempic, have already upended the treatment of both obesity and diabetes, with sales of both drugs skyrocketing.

Now, injected Wegovy could prove a boon for many patients battling heart failure, a new study suggests. The trial results were presented Friday in Amsterdam at the annual meeting of the European Society of C...

As demand for the wildly popular weight-loss drug Wegovy continues to climb, drug maker Novo Nordisk said Thursday that it will continue restrictions on starter doses of the medication into 2024.

The new plan extends by months existing restrictions and means patients who are not already taking the medication will have to wait to start.

“We are going to continue to supply the marke...

A large clinical trial weighing the medical merits of the obesity drug Wegovy has unearthed a significant positive side effect.

Taking the medication cut the risk of serious heart problems by 20%, drug maker Novo Nordisk announced Tuesday.

“People living with obesity have an increased risk of cardiovascular disease but, to date, there are no approved weight-management medications ...

A Louisiana woman is suing the makers of two type 2 diabetes drugs used off-label for obesity, saying they failed to adequately warn about the risk of severe stomach problems.

The lawsuit seeks “very significa...

Water fasting has become one of the trendiest new weight-loss sensations, touted by former athletes and wellness gurus.

But whatever weight is lost during a water fast can come back quickly, while other health benefits fade fast, according to a